Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.17
+1.04 (4.33%)
Apr 14, 2026, 9:48 AM EDT - Market open
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.12 billion as of April 14, 2026. Its market cap has increased by 63.51% in one year.
Market Cap
3.12B
Enterprise Value
2.89B
1-Year Change
63.51%
Ranking
Category
Stock Price
$25.17
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.12B, an increase of 299.12%. That is a compound annual growth rate of 25.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 2.99B | -15.90% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.14B |
| Vera Therapeutics | 3.12B |
| Catalyst Pharmaceuticals | 3.09B |
| Tarsus Pharmaceuticals | 3.09B |
| Denali Therapeutics | 3.08B |
| Tango Therapeutics | 3.08B |
| Oruka Therapeutics | 3.04B |
| Beam Therapeutics | 3.00B |